OV-MZ-6 (Q54936868)

From Wikidata

Jump to navigation Jump to search

cell line

OVMZ-6

Language	Label	Description	Also known as
English	OV-MZ-6	cell line	OVMZ-6

Statements

1 reference

Cellosaurus release 44

27 January 2023

cancer cell line

1 reference

Cellosaurus release 44

27 January 2023

described by source

Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines

1 reference

Cellosaurus release 44

27 January 2023

Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.

1 reference

Cellosaurus release 44

27 January 2023

Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status

1 reference

Cellosaurus release 44

27 January 2023

Expression of urokinase-type plasminogen-activator (upa) and its receptor (upar) in human ovarian-cancer cells and in-vitro invasion capacity

1 reference

Cellosaurus release 44

27 January 2023

Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens.

1 reference

Cellosaurus release 44

27 January 2023

established from medical condition

ovarian serous cystadenoma

1 reference

Cellosaurus release 26

13 June 2018

derived from organism type

1 reference

Cellosaurus release 44

27 January 2023

http://purl.obolibrary.org/obo/BTO_0004487

1 reference

Cellosaurus release 44

27 January 2023

Identifiers

1 reference

Cellosaurus release 44

27 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54936868&oldid=1861683368"